GORDON KUSI: Open Payments
NPI 1457782054 · BELLE MEAD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 23 payments from 6 companies in 2025. Trend: 2023 $666 · 2024 $626 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $138 |
| Lundbeck LLC | 6 | $113 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Teva Pharmaceuticals USA, Inc. | 4 | $65 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Alkermes, Inc. | 1 | $18 |
Products named: VRAYLAR, REXULTI, UZEDY, ABILIFY MAINTENA, SPRAVATO, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across NJ — which companies pay providers there.
